122 related articles for article (PubMed ID: 8632353)
21. Central effect of mu-opioid agonists on antral motility in conscious rats.
Tsuchida D; Fukuda H; Koda K; Miyazaki M; Pappas TN; Takahashi T
Brain Res; 2004 Oct; 1024(1-2):244-50. PubMed ID: 15451387
[TBL] [Abstract][Full Text] [Related]
22. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
24. Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22.
Chen T; Hu Z; Quirion R; Hong Y
Neuropharmacology; 2008 Apr; 54(5):796-803. PubMed ID: 18249418
[TBL] [Abstract][Full Text] [Related]
25. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
26. Intrathecally administered gabapentin inhibits formalin-evoked nociception and the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Kaneko M; Mestre C; Sánchez EH; Hammond DL
J Pharmacol Exp Ther; 2000 Feb; 292(2):743-51. PubMed ID: 10640314
[TBL] [Abstract][Full Text] [Related]
27. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint.
Nagasaka H; Awad H; Yaksh TL
Anesthesiology; 1996 Oct; 85(4):808-16. PubMed ID: 8873551
[TBL] [Abstract][Full Text] [Related]
28. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord.
Presley RW; Menétrey D; Levine JD; Basbaum AI
J Neurosci; 1990 Jan; 10(1):323-35. PubMed ID: 1688935
[TBL] [Abstract][Full Text] [Related]
29. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
Chapman V; Buritova J; Honoré P; Besson JM
J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
[TBL] [Abstract][Full Text] [Related]
30. Pre- versus postformalin effects of ketamine or large-dose alfentanil in the rat: discordance between pain behavior and spinal Fos-like immunoreactivity.
Gilron I; Quirion R; Coderre TJ
Anesth Analg; 1999 Jul; 89(1):128-35. PubMed ID: 10389790
[TBL] [Abstract][Full Text] [Related]
31. Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A.
Drinovac V; Bach-Rojecky L; Matak I; Lacković Z
Neuropharmacology; 2013 Jul; 70():331-7. PubMed ID: 23499661
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal sensory neuron-specific receptor agonists bovine adrenal medulla 8-22 and (Tyr6)-gamma2-MSH-6-12 inhibit formalin-evoked nociception and neuronal Fos-like immunoreactivity in the spinal cord of the rat.
Chen T; Cai Q; Hong Y
Neuroscience; 2006 Aug; 141(2):965-975. PubMed ID: 16713112
[TBL] [Abstract][Full Text] [Related]
33. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord.
Labuz D; Chocyk A; Wedzony K; Toth G; Przewlocka B
Life Sci; 2003 Jun; 73(4):403-12. PubMed ID: 12759135
[TBL] [Abstract][Full Text] [Related]
34. Lesions of the dorsolateral funiculus block supraspinal opioid delta receptor mediated antinociception in the rat.
Kovelowski CJ; Ossipov MH; Hruby VJ; Porreca F
Pain; 1999 Nov; 83(2):115-22. PubMed ID: 10534582
[TBL] [Abstract][Full Text] [Related]
35. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
36. Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test.
Yamamoto T; Miyazaki R; Yamada T
Peptides; 2009 Sep; 30(9):1683-8. PubMed ID: 19520126
[TBL] [Abstract][Full Text] [Related]
37. Inhalation anesthetics suppress the expression of c-Fos protein evoked by noxious somatic stimulation in the deeper layer of the spinal cord in the rat.
Hagihira S; Taenaka N; Yoshiya I
Brain Res; 1997 Mar; 751(1):124-30. PubMed ID: 9098575
[TBL] [Abstract][Full Text] [Related]
38. Protein c-fos induction in rat brain and spinal dorsal horn by sincalide and opioids in vitro.
Chen SZ; Han JS
Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):426-9. PubMed ID: 7717068
[TBL] [Abstract][Full Text] [Related]
39. Effects of R-84760, a selective kappa-opioid receptor agonist, on nociception, locomotion and respiration in rats.
Fujibayashi K; Kubota-Watanabe M; Iizuka Y
Arch Int Pharmacodyn Ther; 1996; 331(2):153-62. PubMed ID: 8937626
[TBL] [Abstract][Full Text] [Related]
40. Antinociception of heterotopic electro-acupuncture mediated by the dorsolateral funiculus.
Lee SJ; Lyu YS; Kang HW; Sohn IC; Koo S; Kim MS; Park BR; Song JH; Kim JH
Am J Chin Med; 2007; 35(2):251-64. PubMed ID: 17436366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]